These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24190226)

  • 1. Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats.
    Arima S; Uto H; Ibusuki R; Kumamoto R; Tanoue S; Mawatari S; Oda K; Numata M; Fujita H; Oketani M; Ido A; Tsubouchi H
    Int J Mol Med; 2014 Jan; 33(1):68-76. PubMed ID: 24190226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.
    Ibusuki R; Uto H; Arima S; Mawatari S; Setoguchi Y; Iwashita Y; Hashimoto S; Maeda T; Tanoue S; Kanmura S; Oketani M; Ido A; Tsubouchi H
    Liver Int; 2013 Nov; 33(10):1549-56. PubMed ID: 23682724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy improves insulin resistance and serum levels of interleukin-6 and -10 in spontaneously hypertensive rats with steatohepatitis.
    Kozono M; Uto H; Ibusuki R; Arima S; Oda K; Taguchi H; Sasaki F; Nasu Y; Hashimoto S; Setoyama H; Kanmura S; Numata M; Tsubouchi H; Ido A
    Mol Med Rep; 2016 Dec; 14(6):5385-5394. PubMed ID: 27779710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats.
    Hayashizaki-Someya Y; Kurosaki E; Takasu T; Mitori H; Yamazaki S; Koide K; Takakura S
    Eur J Pharmacol; 2015 May; 754():19-24. PubMed ID: 25701721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease.
    Yamamoto H; Kanno K; Ikuta T; Arihiro K; Sugiyama A; Kishikawa N; Tazuma S
    J Hepatobiliary Pancreat Sci; 2016 May; 23(5):260-9. PubMed ID: 26880573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Kawaguchi K; Sakaida I; Tsuchiya M; Omori K; Takami T; Okita K
    Biochem Biophys Res Commun; 2004 Feb; 315(1):187-95. PubMed ID: 15013444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
    Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model.
    Burgueño AL; Gianotti TF; Mansilla NG; Pirola CJ; Sookoian S
    Clin Sci (Lond); 2013 Jan; 124(1):53-63. PubMed ID: 22827449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats.
    Nishi T; Yamamoto Y; Yamagishi N; Iguchi M; Tamai H; Ito T; Tsuruo Y; Ichinose M; Kitano M; Ueyama T
    J Pharm Pharmacol; 2018 Mar; 70(3):383-392. PubMed ID: 29355950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.
    Suzuki-Kemuriyama N; Abe A; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
    Lipids Health Dis; 2020 Dec; 19(1):251. PubMed ID: 33317575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
    Luo F; Ishigami M; Achiwa K; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Ishikawa T; Katano Y; Goto H
    Dig Dis Sci; 2015 Sep; 60(9):2730-9. PubMed ID: 25868633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.
    Rao A; van de Peppel IP; Gumber S; Karpen SJ; Dawson PA
    Front Med (Lausanne); 2020; 7():60. PubMed ID: 32158763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.
    Yoshimine Y; Uto H; Kumagai K; Mawatari S; Arima S; Ibusuki R; Mera K; Nosaki T; Kanmura S; Numata M; Tamai T; Moriuchi A; Tsubouchi H; Ido A
    Oncol Rep; 2015 Apr; 33(4):1657-66. PubMed ID: 25607821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
    Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E
    Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways.
    Yuan Y; Naito H; Jia X; Kitamori K; Nakajima T
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of heme oxygenase-1 in non-alcoholic steatohepatitis].
    Wang RQ; Nan YM; Han F; Zhao SX; Fu N; Wu WJ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):680-4. PubMed ID: 20943080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet.
    Oliveira CP; da Costa Gayotto LC; Tatai C; Della Bina BI; Janiszewski M; Lima ES; Abdalla DS; Lopasso FP; Laurindo FR; Laudanna AA
    J Cell Mol Med; 2002; 6(3):399-406. PubMed ID: 12417056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.